Skip to main content
SpringerLink
Log in

Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry

  • Original Articles
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The increasing use of neoadjuvant chemotherapy and endocrine therapy in the management of breast cancer has lead us to evaluate and optimise the standard technique of cytocentrifugation of a single fine needle aspirate (FNA) taken from a breast tumour in-vivo, to determine a range of both immunocytochemical and flow cytometric factors which are predictive of response to primary medical therapy. Some of these factors are also of prognostic significance in early stage disease. An analysis of the cellularity and immunocytochemical staining characteristics of FNAs obtained from a series of 206 patients with palpable breast cancers indicate that in a sample of 46 cases it is possible to measure oestrogen receptor, progesterone receptor and c-erbB-2 providing over 400 cells per slide are obtained, with material obtained in a single FNA prepared by cytocentrifugation, using standard immunocytochemical methods. The staining results obtained were comparable to those obtained using frozen or paraffin embedded tissue sections taken from the same tumour. In addition an estimate of the proliferation indices could be made by flow cytometric analysis of the residual cell suspension fluid with measurement of DNA index and S-phase fraction in 131/164 (80%) and 110/164 (67%) of cases respectively. Providing all FNAs obtained for cytocentrifugation were taken at first presentation rather than immediately following a standard FNA, then it was possible to obtain adequately cellular (>400 cells/slide) samples in 96 out of 126 (75%) of the last cohort of breast aspirates. These effects may be independent of T stage but not histological type as patients with lobular tumours only produced cellular aspirates in 1/7 (14%) of cases. The advantages and disadvantages of using FNA over trucut biopsy are discussed further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abendroth CS, Wang HH, Ducatman BS (1991) Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine needle aspiration biopsy specimens. Am J Clin Pathol 96:654–659

    Google Scholar 

  2. Berg JW, Robbins GF (1962) A late look at the safety of aspiration biopsy. Cancer 15(4):826–827

    Google Scholar 

  3. Bonadonna G, Veronesi U, Bambilla C, et al. (1990) Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimetres or more. J Natl Cancer Inst 82(19):1539–1545

    Google Scholar 

  4. Bradbeer JW (1985) Out-patient diagnosis of breast cancer. Br J Surg 72:927–928

    Google Scholar 

  5. Clare N, Rone R (1986) Detection of malignancy in body fluids. Lab Med 17(3):147–150

    Google Scholar 

  6. Coombes RC, Powles TJ, Berger U, et al. (1987) Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine needle aspirates. Lancet II 701–703

    Google Scholar 

  7. Davies N, Moir G, Carpenter R et al. (1991) ERICA predicts response to tamoxifen in elderly women with breast cancer. Ann R Coll Surg 73:361–363

    Google Scholar 

  8. Ducatman BS, Hogan CL, Wang HH (1989) A triage system for processing fine needle aspiration cytology specimens. Acta Cytologica 33(6):797–799

    Google Scholar 

  9. Dundas SAC, Sanderson PR, Matta H, Shorthouse AJ (1988) Fine needle aspiration of palpable breast lesions. Acta Cytologica 32(2):202–205

    Google Scholar 

  10. Engzell U, Esposti CR, Sigurdson A, et al. (1971) Investigation on tumour spread in connection with aspiration biopsy. Acta Radiological 10(4):385–397

    Google Scholar 

  11. Fernando IN; McRobert L, Smith D, et al. (1992) Determination of immunocytochemical prognostic factors in breast cancer using a single fine needle aspirate. Br J Cancer 66[Suppl XVII] 8

    Google Scholar 

  12. Fernando IN, Allan SM, Sandle J, Dean C, Sacks N, Trott PA (1993) Immunoytochemical staining for the c-erbB-2 gene product in breast aspirates. Cytopathology 4(4):219–223

    Google Scholar 

  13. Fisher B, Wickerham DL (1991) Pre-operative systemic therapy for the treatment of primary breast cancer. In: Medical management of breast cancer. Martin Dunitz, Powles TJ, Smith IE (eds)

  14. Galea MH, Dilks B, Ellis IO (1992) Flow and static cytometry in the automated analysis of grading in breast cancer. The Breast 1 (2):149

    Google Scholar 

  15. Gazet JC, Markopoulos C, Ford HT, et al. (1988) Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. Lancet I:679–681

    Google Scholar 

  16. Gilchrist KW, Kalish L, Gould VE, et al. (1985) Interobserver reproducibility of histopathological features in stage II breast cancer. Breast Cancer Res Treat 5:3–10

    Google Scholar 

  17. Gusterson BA, Gelber RD, Goldhirsch A, et al. (1992) Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 10(7):1049–1056

    Google Scholar 

  18. Kalloniemi O (1988) Comparison of fresh and paraffin embedded tissue as starting material for DNA flow cytometry and evaluation of intratumuoral heterogeneity. Cytometry 9:164–169

    Google Scholar 

  19. Lagios MD, Margolin FR, Westdahl PR, et al. (1989) Mammographically detected duct carcinoma in situ. Cancer 63:608–624

    Google Scholar 

  20. Lamb JL, Anderson TJ (1989) Influence of cancer histology on the success of FNA of breast. J Clin Pathol 42:733–739

    Google Scholar 

  21. Masood S, Dee S, Hardy NM, et al. (1990) Cytospin preparation for assessment of hormone receptors in fine needle aspiration. J Histotechnol 13(1):23–25

    Google Scholar 

  22. Muss HB, Thor A, Berry D, Kute T, et al. (1994) C-erbB-2 expression and response to adjuvant therapy in women with node positive early breast cancer. N Engl J Med 330 (18):1260–1266

    Google Scholar 

  23. O'Reilly SM, Camplejohn RS, Rubens RD, Richards MA (1992) DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer. Eur J Cancer 28(2/3):681–683

    Google Scholar 

  24. Ormerod MG (1994) Analysis of DNA: general methods. In: Flow cytometry: a Practical Approach. 2nd edn., Oxford University Press, pp 119–135

  25. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL (1980) The value of oestrogen and progesterone receptors in the treatment of breast cancer. Cancer 46:2884–2888

    Google Scholar 

  26. Powles TJ, Trott PA, Cherryman G, et al. (1991) Fine needle aspiration cytodiagnosis as a pre-requisite for primary medical treatment of breast cancer. Cytopathology 2:7–12

    Google Scholar 

  27. Robbins GF, Brothers JH, Eberhart WF, et al. (1954) Is aspiration biopsy at breast cancer dangerous to the patient? Cancer 7(4):774–778

    Google Scholar 

  28. Roger V, Brennhovd I, Hoeg K (1972) Tumour cells in the blood: the prognostic significance of tumour cells in blood during palpation and biopsy. Acta Cytol 16(6):557–560

    Google Scholar 

  29. Rubens RD, Bartelink H, Engelsman E, et al. (1989) Locally advanced breast cancer: the contribution of cytotoxic chemotherapy and endocrine treatment to radiotherapy. Eur J Cancer Clin Oncol 25:667–678

    Google Scholar 

  30. Silverstein MJ, Wasisman JR, Gamagami P, et al. (1990) Intraductal carcinoma of the breast. Cancer 66(1):102–108

    Google Scholar 

  31. Stomper PC, Connoly JL, Meyer JE, et al. (1989) Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiological-pathological correlation. Radiology 172(1):235–241

    Google Scholar 

  32. Stenkvist B, Bengtsson E, Eriksson O, et al. (193) Histopathological systems of breast cancer classification: reproducibility and clinical significance. J Clin Pathol 36:392–398

    Google Scholar 

  33. Styles JM, Harrison S, Gusterson BA, Dean CJ, et al. (1990) Rat monoclonal antibodies to the external domain of the product of c-erbB-2 proto-oncogene. Int J Cancer 45(2):320–324

    Google Scholar 

  34. Trott PA (1991) Aspiration cytodiagnosis of the breast. Diagn Oncol 1:79–87

    Google Scholar 

  35. Wang HH, Ducatman BS, Eick D (1989) Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine needle aspiration biopsy. Am J Clin Pathol 92:736–740

    Google Scholar 

  36. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. (1992) Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol 10(3):356–363

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Breast Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK

    I. N. Fernando, T. J. Powles, A. Nash & M. C. Nicolson

  2. Department of Radiotherapy and Oncology, Royal Marsden Hospital, Sutton, UK

    H. T. Ford

  3. Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London, UK

    M. Dowsett

  4. Department of Cytopathology, Royal Marsden Hospital, London, UK

    L. McRobert & P. A. Trott

  5. Department of Academic surgery, Royal Marsden Hospital, Sutton, UK

    N. Sacks & S. M. Allan

  6. Department of Statistics, Royal Marsden Hospital, Sutton, UK

    S. Ashley

  7. Institute of Cancer Research, Cotswold Road, Sutton, Surrey, UK

    J. Titley & M. G. Ormerod

Authors
  1. I. N. Fernando
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. J. Powles
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Nash
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. C. Nicolson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. T. Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Dowsett
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. McRobert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. A. Trott
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N. Sacks
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S. M. Allan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S. Ashley
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J. Titley
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. M. G. Ormerod
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernando, I.N., Powles, T.J., Nash, A. et al. Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry. Vichows Archiv A Pathol Anat 426, 155–161 (1995). https://doi.org/10.1007/BF00192637

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00192637

Key words

Search

Navigation